Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

IQ-AI subsidiary Imaging Biometrics (IB) was awarded a U.S. patent for its artificial intelligence (AI) software technology that eliminates the need for gadolinium-based contrast agents (GBCAs) in medical imaging exams.
News | Contrast Media | June 30, 2021
Imaging Biometrics Awarded Patent for No-contrast MRI Exams
June 30, 2021 – IQ-AI subsidiary Imaging Biometrics (IB) was awarded a U.S. patent for its artificial intelligence (AI...
read more
According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.

Getty Images

News | Magnetic Resonance Imaging (MRI) | May 12, 2021
Using Contrast MRI After a Heart Attack Could Increase Survival
May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27...
read more
The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul
News | Contrast Media | May 11, 2021
Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (...
read more
The contrast agents global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $7,033.5 million by 2027 due to the increasing incidence and prevalence of chronic diseases and demand for diagnostic and interventional radiology procedures, increase in aging population, expansion of contrast agent indications, the growth of medical imaging in the emerging market, increasing research activities and favorable reimbursement

image courtesy of Guerbet

News | Contrast Media | May 03, 2021
Contrast Media Agents Global Market
Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or...
read more
Sponsored Content | Blog | Contrast Media Injectors | April 29, 2021
BLOG: Smart Injector Technology Delivers Effective and Efficient Patient Care
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the...
read more
Gadopiclenol is a high-relaxivity macrocyclic contrast agent used for magnetic resonance imaging (MRI)
News | Contrast Media | March 24, 2021
Gadopiclenol has Positive Results for Phase III Clinical Trials 
March 24, 2021 — Guerbet announced positive results from two Phase III clinical studies comparing the diagnostic...
read more
(a) High-resolution 3D MRI brain vascular map using SAIO. Various blood vessels in the rat brain can be visualized. In addition to clinically important brain vessels including anterior cerebral artery, middle cerebral artery, posterior cerebral artery, fine vessel structures as thin as ~ 100 microns in diameter can be clearly visualized. (b) 3D MRI brain vascular map using Dotarem (gadolinium-based contrast agent). Resolution is low and microvessels are not visible. (c) For 3D reconstruction, multiple slice

(a) High-resolution 3D MRI brain vascular map using SAIO. Various blood vessels in the rat brain can be visualized. In addition to clinically important brain vessels including anterior cerebral artery, middle cerebral artery, posterior cerebral artery, fine vessel structures as thin as ~ 100 microns in diameter can be clearly visualized. (b) 3D MRI brain vascular map using Dotarem (gadolinium-based contrast agent). Resolution is low and microvessels are not visible. (c) For 3D reconstruction, multiple slices of MRI images of the rat heart were obtained after injection of SAIO. Rat coronary arteries (180 microns) which are 10 times thinner than human coronary arteries were successfully visualized. Coronary arteries supply blood to the heart muscle and the blockage or narrowing of such arteries causes myocardial infarction or angina, but visualizing these arteries was impossible due to the limited resolution of current MRI contrast agents. Image courtesy of Institute for Basic Science

News | Contrast Media | March 12, 2021
A Safer MRI Contrast Agent for High-resolution 3-D Microvascular Imaging
March 12, 2021 — Heart attack and stroke are the first and second leading causes of death in developed countries,...
read more
Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
Guerbet Launches OptiProtect 3S
February 25, 2021 — Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection...
read more
Steinberg Diagnostic Medical Imaging headquarters.

Steinberg Diagnostic Medical Imaging headquarters.

Sponsored Content | Case Study | Contrast Media Injectors | January 21, 2021
Steinberg Diagnostic Medical Imaging
Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years ago and has grown to be one of the largest outpatient...
read more
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
2021 Outlook for the Contrast Media Injectors Market
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was...
read more
new study published on European Radiology evaluates the image quality of low iodine concentration, dual-energy CT (DECT) combined with a deep learning–based denoising technique with ClariCT.AI for pediatric abdominal CT, compared with that of standard iodine concentration single-energy polychromatic CT (SECT).
News | Artificial Intelligence | January 19, 2021
New Study Shows Value of Low-concentration Iodine When Paired with Dual-Energy CT and DL Technique
January 19, 2021 — Radiation exposure and side effects related to iodine contrast agents are the two main concerns of...
read more
This novel agent, based on the essential nutrient manganese, has strong potential as a safer alternative to currently used contrast agents
News | Contrast Media | December 28, 2020
Novel MRI Contrast Agent Sidesteps Toxic Effects of Current Products
December 28, 2020 — Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image...
read more
Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.
News | Radiation Dose Management | December 11, 2020
Bayer Radiology Announces Transformation of Radimetrics
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose...
read more
GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent, Clariscan (gadoterate meglumine), in pre-filled syringes. #RSNA20
News | Contrast Media | November 26, 2020
GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan in Pre-Filled Syringes
November 26, 2020 — GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent...
read more
Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging solutions in an immersive digital experience at the first all-virtual Radiological Society of North America (RSNA) annual meeting being held November 29 through December 5.
News | Contrast Media Injectors | November 17, 2020
Bracco Showcases Immersive Digital Experience at RSNA20
November 17, 2020 — Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging...
read more
Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the 2020 annual meeting of the Radiological Society of North America (RSNA).
News | Contrast Media | November 17, 2020
Guerbet to Showcase its UNIK Solution at RSNA 2020
November 17, 2020 — Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the...
read more
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

Feature | Magnetic Resonance Imaging (MRI) | October 29, 2020
Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very...
read more
When new installations are ordered, the DAS team at Bracco matches a specialist with the installation based on specialty, learning style and industry awareness. This approach was helpful at Beaufort Memorial Hospital in Beaufort, S.C., which just recently transitioned to the Bracco EmpowerCTA+ Injector System.
Sponsored Content | Blog | Contrast Media | October 20, 2020
BLOG: Training and Vendor Support Key to Successful Device Upgrade
Transitioning to a new device vendor can provide improvements to outdated technology and workflow. It also requires a...
read more
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
Contrast Media Injectors Market Projected at $1.9 billion by 2025
September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector...
read more
The radiology department uses Bracco’s Empower CTA injector system and has a been a Bracco customer for more than 15 years.
Sponsored Content | Blog | Contrast Media Injectors | August 20, 2020
BLOG: Reliability and Customer Service Key to Injector Uptime and CT Department Workflow
In a busy hospital imaging department, maintaining high device uptime levels is critical. If an injector malfunctions...
read more
© Copyright Wainscot Media. All Rights Reserved.